As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

Donepezil was associated with improved verbal memory and enhanced recall and processing speed compared to placebo in patients with severe traumatic brain injury (TBI), with a favorable safety ...

Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...

BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), a pharmaceutical company with a market capitalization of ...

Due to the well-known cholinergic deficit in this disease, Mori and colleagues (2012) explored the use of a cholinesterase inhibitor, donepezil, for the treatment of DLB. The authors enrolled ...

Donepezil+Memantine is a prescription medicine used to treat Alzheimer's disease. It helps to slow down the progression of moderate to severe Alzheimer's by improving memory and thinking.

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...